|
Postings for Healthcare Providers
|
Date Posted
|
|
Questioning Approval of the Watchman Device for Atrial Fibrillation.
|
December 2017
|
|
How Should We Prevent Blood Clots Following Arthroscopic Knee Surgery? Cynthia’s Story and a Limited Discussion of the Literature
|
November 2017
|
|
Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future?
|
September 2017
|
|
Chronic Thromboembolic Pulmonary Hypertension Day
|
November 2014
|
|
A Review of the suggested anti-cancer benefits of warfarin, low-molecular weight heparin, and aspirin
|
February 2014
|
|
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants
|
February 2014
|
|
Silver Book: Atrial Fibrillation Fact Sheet
|
August 2013
|
|
DVT Blood Clots Awareness Video
|
March 2013
|
|
Acute Stroke Guidelines promote organized systems of care, intravenous fibrinolysis & caution with new anticoagulants and endovascular interventions
|
March 2013
|
|
Rivaroxaban (and similar agents) for extended prophylaxis of venous thrombosis in high risk medical patients – equal efficacy but increased bleeding
|
March 2013
|
|
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
|
January 2013
|
|
Dabigatran (Pradaxa) Should NOT be used in Mechanical Heart Valve Patients
|
January 2013
|
|
Deep Vein Thrombosis and Pulmonary Embolism Brochure from Clot Connect
|
January 2013
|
|
Aspirin, Apixaban, or Warfarin for Extended Treatment of Venous Thrombosis?
|
January 2013
|
|
Alliance for Aging Research Releases Survey of AFib Patients 65+ that Finds Active Participation in Treatment Decisions
|
November 2012
|
|
Novel Anticoagulants Should not Replace Warfarin; Head-to-Head Trial Needed
|
September 2012
|
|
Assessing Stroke & Bleeding Risk in Atrial Fibrillation: Expert Consensus
|
July 2012
|
|
Unstable Angina/Non-ST-Elevation Myocardial Infarction: Updated Guideline
|
July 2012
|
|
The allure of endovascular intervention for stroke prevention fails to de
|
July 2012
|
|
Rivaroxaban approved for stroke prevention in non-valvular atrial fibrill
|
February 2012
|
|
New Chest Guidelines Available Now
|
February 2012
|
|
Apixaban in VTE prevention in knee surgery compared to enoxaparin – Confl
|
December 2011
|
|
Rivaroxaban vs a Vitamin K antagonist (EINSTEIN-DVT trial)
|
July 2011
|
|
Experts warn against the use of dosing protocols for managing warfarin th
|
December 2010
|
|
FDA approves Pradaxa (dabigatran) to prevent stroke in people with atrial
|
October 2010
|
|
Warfarin Better than Dabigatran and Vice Versa in Some Patients with Atri
|
October 2010
|
|
FDA Recommends Dabigatran Approval: Agree with no ASA, still skeptical on
|
October 2010
|
|
Medication Errors in Cardiovascular & Stroke Patients
|
June 2010
|
|
Dabigatran vs. Warfarin in Atrial Fibrillation; Reluctant to Rely on RE-L
|
March 2010
|
|
New study and accompanying editorial suggest that warfarin may be indicat
|
January 2010
|
|
Video: Current and Emerging Trends in DVT Prophylaxis
|
October 2009
|
|
Warfarin (Coumadin) Video from AHRQ
|
October 2009
|
|
INR Patient Self Testing Video Demo
|
October 2009
|
|
Warfarin (Coumadin) Patient Education Video
|
August 2009
|
|
Medicare proposes decision NOT to pay for genetic testing for warfarin (C
|
July 2009
|
|
Does Warfarin Prevent Catheter-related Thrombosis in Cancer Patients? Yes
|
June 2009
|
|
What is the Real Scoop on Aspirin + Clopidogrel in Atrial Fibrillation?
|
May 2009
|
|
Study Finds No Benefit of Low-dose Vitamin K Administration for High INRs
|
May 2009
|
|
Genetic (VKORC1) sensitivity to warfarin may predict limited effect of da
|
September 2008
|
|
Computer-assisted dosing programs perform well when used by experienced c
|
July 2008
|
|
Is it Safe to Send Stable Anticoagulation Clinic Patients Back to Usual M
|
April 2008
|
|
Dietary and Herbal Supplements in Patients on Anticoagulation – Serious U
|
February 2008
|
|
Anticoagulation Safety a Hospital Priority for 2008
|
January 2008
|
|
Non-bleeding Complications of Warfarin Therapy – Opposing Views & the Nee
|
October 2007
|
|
Warfarin more effective and at least as safe as low dose aspirin in elder
|
September 2007
|
|
Bleeding rates are higher in those over 80 years old when started on warf
|
September 2007
|
|
Dietary Supplements & Oral Anticoagulants - A Registry of Interactions
|
August 2007
|
|
Genetic Testing for Warfarin (Coumadin) Dosing? - Not Yet Ready for Prime
|
July 2007
|
|
Poor adherence as a potential source of poor anticoagulation control
|
April 2007
|
|
Should we shorten treatment of DVT and PE to 3 months? Not yet.
|
April 2007
|
|
Should 3rd Generation Birth Control Pills be Banned? - Petition to Ban 3r
|
March 2007
|
|
Should 3rd Generation Birth Control Pills be Banned? - Opposition to a Pe
|
March 2007
|
|
Should we be treating fewer patients with warfarin (Coumadin)?
|
March 2007
|
|
Should we be treating more patients with warfarin (Coumadin)?
|
March 2007
|
|
Can better INR control be achieved, and if so, how will new anticoagulant
|
March 2007
|
|
PCC Products and Reversing Warfarin
|
March 2007
|
|
Telephone Versus In-Office Anticoagulation Management
|
January 2007
|
|
The Pulmonary Embolism Support Group - Support for Individuals with DVT o
|
January 2007
|
|
d-Dimer Found Useful in Decision to Continue Anticoagulation Following Fi
|
December 2006
|
|
Atrial fibrillation (AF) more than twice as prevalent as thought - and it
|
August 2006
|
|
Diagnosis, risk-stratification, and management of patients with antiphosp
|
July 2006
|
|
New Guidelines to Reduce DVT Risk in Cancer Patients
|
April 2006
|
|
Long-term warfarin may increase osteoporotic fractures in men but not wom
|
March 2006
|
|
Help Make History at the DVT Coalition Kick-off Event
|
February 2006
|
|
AstraZeneca Decides to Withdraw Exanta
|
February 2006
|
|
Major Bleeding Events Lead to Under Use of Anticoagulation in Atrial Fibr
|
February 2006
|
|
Daily Low-dose Vitamin K Supplementation Stabilizes INRs
|
February 2006
|
|
Poor Early Anticoagulation Control Associated with Near 3-fold Increase i
|
January 2006
|
|
New Data Fuels Continued Controversy About Anti-Phospholipid Antibody (AP
|
November 2005
|
|
Should I stop my patients warfarin prior to a dental procedure?
|
October 2005
|
|
Appropriate Use of Anticoagulation in Atrial Fibrillation Patients Dramat
|
October 2005
|
|
Where can I find an anticoagulation expert near my home or office?
|
October 2005
|
|
Advanced age affects major bleeding and major thromboembolic rates in pat
|
October 2005
|
|
Warfarin and Aspirin Combination in Acute Coronary Syndrome
|
August 2005
|
|
Largest study yet confirms benefits of clinical pharmacy managed anticoag
|
May 2005
|
|
New Data on Aspirin vs. Warfarin in TIA Patients, but Questions Persist
|
March 2005
|
|
NIH Conference on Dietary Supplements, Coagulation, and Antithrombotic Th
|
March 2005
|
|
What Happened to Ximelagatran?
|
March 2005
|
|
Self-Management of Oral Anticoagulation
|
March 2005
|
|
D-Dimer Testing to Exclude Recurrent DVT
|
January 2005
|
|
New Study Supports INR of 2 to 3 for Elderly Patients with A. Fib.
|
November 2004
|
|
Anticoagulation Education and Reduced Bleeding in the Elderly
|
October 2004
|
|
FDA Rejects Ximelagatran (brand name Exanta)
|
October 2004
|
|
Study and Editorial Address Three-Fold Greater Recurrence of DVT in Men
|
September 2004
|
|
Exanta not Recommended by FDA Advisory Panel, Causes M.I.s?
|
September 2004
|
|
Genetic Variation in Warfarin Metabolism
|
September 2004
|
|
New Supplement Devoted to Factor Xa Inhibitors (fondaparinux)
|
August 2004
|
|
Excessive Anticoagulation Associated with Increased Mortality and Morbidi
|
August 2004
|
|
Is Warfarin-Induced Bleeding Increasing?
|
August 2004
|
|
Anticoagulation in Special Populations
|
August 2004
|
|
Treatment of Deep Vein Thrombosis
|
August 2004
|
|
An Overview of Anticoagulants, Antiplatelet Agents, and the Combination i
|
May 2004
|
|
The Use of Low Dose Vitamin K to Stabilize INR Fluctuation During Warfari
|
May 2004
|
|
New Anticoagulants to Displace or Reshape Anticoagulation Clinics
|
April 2004
|
|
New Data on Treatment Duration for Provoked DVT
|
April 2004
|
|
Hot Topic: The Optimal Range of Oral Anticoagulation in Patients with Mec
|
March 2004
|
|
Ximelagatran (brand name Exanta) is Leading the Coming Revolution in Stro
|
January 2004
|